FFM
DNA icon

Forum Financial Management’s Ginkgo Bioworks DNA Stock Holding History

Forum Financial Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-250
Closed -$3.34K – 772
2024
Q2 		$3.34K Hold
250
– – ﹤0.01% 716
2024
Q1 		$11.6K Buy
+250
New +$12.9K ﹤0.01% 740
2023
Q4 		– Sell
-305
Closed -$22.1K – 697
2023
Q3 		$22.1K Hold
305
– – ﹤0.01% 637
2023
Q2 		$22.7K Hold
305
– – ﹤0.01% 654
2023
Q1 		$16.2K Hold
305
– – ﹤0.01% 619
2022
Q4 		$20.6K Hold
305
– – ﹤0.01% 592
2022
Q3 		$38K Buy
305
+5
+2% +$596 ﹤0.01% 536
2022
Q2 		$29K Hold
300
– – ﹤0.01% 571
2022
Q1 		$48K Buy
+300
New +$58.4K ﹤0.01% 605

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Forum Financial Management's DNA Position: Q3 2024 in Review

Forum Financial Management sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 250 shares — an estimated $3.34K sold.

Forum Financial Management first reported a position in DNA in Q1 2022 and held it in 9 quarters. The position peaked at $48K in Q1 2022. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Forum Financial Management reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Forum Financial Management sold 250 Ginkgo Bioworks shares in Q3 2024, an estimated $3.34K.
  • Forum Financial Management first reported a position in Ginkgo Bioworks in Q1 2022 and held it in 9 quarters.
  • Forum Financial Management's Ginkgo Bioworks position peaked at $48K in Q1 2022.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Forum Financial Management's 13F filing for Q3 2024, filed 29 Oct 2024.